3rd Quarter - Amendment

INDEPENDENT PHARMACY COOPERATIVE for INDEPENDENT PHARMACY COOPERATIVE

Firm
Client
Income
—
Expenses
$10,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 10, 2012 $10,000 Replaced
3rd Quarter - Amendment (this page) Aug 22, 2013 $10,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

CMS Aerage Manufacturer Price (AMP) Final Rule, Reporting by manufacturers and calculation. Potential prescription drug track-and-trace legislation. RxTEC National Average Drug Aquisition Cost (NADAC) implementation. Calculation and process. National Average Retail Price (NARP) implementation

LobbyistCovered position, as disclosed
JIM DRISCOLL —
MARK EUGENE KINNEY —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.